An Open-Label Extension Study to Investigate Safety and Tolerability of ML-004 in Adolescents and Adults with Autism Spectrum Disorder (ASD)

ML-004-003 is a multi-center, open-label extension study that will enroll approximately 120 adolescent and adult subjects with ASD that have completed study ML-004-002. The primary objective of the study will be to evaluate the safety of ML-004 in subjects with ASD.

Study ID: 3963
NCT Number: NCT05889273
Principal Investigator: Benjamin Black, MD
Department: Pediatrics-Devel/Behavioral
Eligibility: Both men and women 12 years old to 46 years old. Does not accept healthy volunteers.

For questions about this study, please contact:

ClinicalTrialsInterest@health.missouri.edu
(573) 882-7026